Víctor Acuña-Alonzo Selected Research

HLA-DR14

9/2016

[HLA class II in Mexican patients with pemphigus vulgaris: shared epitope for autoimmunity].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Víctor Acuña-Alonzo Research Topics

Disease

2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 03/2019
2	Obesity 11/2018 - 07/2010
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Neuromyelitis Optica (Devic's Disease) 01/2021
1	Pemphigus (Pemphigus Vulgaris) 09/2016
1	Type 2 Diabetes Mellitus (MODY) 07/2010

Drug/Important Bio-Agent (IBA)

2	HDL CholesterolIBA 01/2021 - 07/2010
1	Thymopoietins (TP 49)IBA 01/2021
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2021
1	Uric Acid (Urate)IBA 03/2019
1	Amylases FDA Link 11/2018
1	Desmoglein 3IBA 09/2016
1	HLA-DR14IBA 09/2016
1	AntibodiesIBA 09/2016
1	EpitopesIBA 09/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2016
1	HLA-DR Antigens (HLA-DR)IBA 09/2016
1	Immunoglobulin G (IgG)IBA 09/2016
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 09/2016
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 09/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2010
1	CholesterolIBA 07/2010